tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KOD Stock Latest News

Kodiak Sciences: GLOW2 Readout as Key Catalyst for Tarcocimab Upside and Broader Pipeline Optionality
RatingsKodiak Sciences: GLOW2 Readout as Key Catalyst for Tarcocimab Upside and Broader Pipeline Optionality
4d ago
KOD
Kodiak Sciences price target raised to $38 from $26 at H.C. Wainwright
PremiumThe Fly
Kodiak Sciences price target raised to $38 from $26 at H.C. Wainwright
15d ago
KOD
Aligos Therapeutics initiated with a Buy at UBS
PremiumThe Fly
Aligos Therapeutics initiated with a Buy at UBS
30d ago
IVA
KOD
Kodiak Sciences assumed with a Buy at UBS
PremiumThe Fly
Kodiak Sciences assumed with a Buy at UBS
30d ago
KOD
Kodiak Sciences Raises Capital Through Completed Stock Offering
PremiumCompany Announcements
Kodiak Sciences Raises Capital Through Completed Stock Offering
2M ago
8K
KOD
Kodiak Sciences 6.956M share Spot Secondary priced at $23.00
PremiumThe FlyKodiak Sciences 6.956M share Spot Secondary priced at $23.00
2M ago
KOD
Closing Bell Movers: Ford nudges higher raised outlook, EV charge
Premium
The Fly
Closing Bell Movers: Ford nudges higher raised outlook, EV charge
2M ago
F
F
Kodiak Sciences announces 6M share offering of common stock
Premium
The Fly
Kodiak Sciences announces 6M share offering of common stock
2M ago
KOD
Kodiak Sciences’ Promising Outlook: Buy Rating Affirmed Amid Positive Drug Developments and Strategic Adjustments
PremiumRatings
Kodiak Sciences’ Promising Outlook: Buy Rating Affirmed Amid Positive Drug Developments and Strategic Adjustments
3M ago
KOD
Kodiak Sciences price target raised to $26 from $24 at H.C. Wainwright
PremiumThe Fly
Kodiak Sciences price target raised to $26 from $24 at H.C. Wainwright
3M ago
KOD
Kodiak Sciences: Promising Pipeline and Strategic Differentiation Drive Buy Rating
PremiumRatings
Kodiak Sciences: Promising Pipeline and Strategic Differentiation Drive Buy Rating
3M ago
KOD
Kodiak Sciences Faces Financial Challenges Amid R&D Focus
PremiumCompany Announcements
Kodiak Sciences Faces Financial Challenges Amid R&D Focus
3M ago
KOD
Kodiak Sciences reports Q3 EPS ($1.16), consensus ($1.04)
PremiumThe FlyKodiak Sciences reports Q3 EPS ($1.16), consensus ($1.04)
3M ago
KOD
Kodiak Sciences upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
Kodiak Sciences upgraded to Buy from Neutral at H.C. Wainwright
3M ago
KOD
Is KOD a Buy, Before Earnings?
Premium
Pre-Earnings
Is KOD a Buy, Before Earnings?
3M ago
KOD
Kodiak Sciences’ KSI-101: Promising Phase 1b Results and Competitive Edge Justify Buy Rating
PremiumRatings
Kodiak Sciences’ KSI-101: Promising Phase 1b Results and Competitive Edge Justify Buy Rating
3M ago
KOD
Kodiak Sciences reports data from study of KSI-101 in patients with MESI
PremiumThe Fly
Kodiak Sciences reports data from study of KSI-101 in patients with MESI
3M ago
KOD
Kodiak Sciences’ Phase 3 Trial: A Potential Game-Changer for Macular Edema Treatment
PremiumCompany Announcements
Kodiak Sciences’ Phase 3 Trial: A Potential Game-Changer for Macular Edema Treatment
3M ago
KOD
Kodiak Sciences’ Phase 3 Study on KSI-101: A Potential Game-Changer for Macular Edema
PremiumCompany Announcements
Kodiak Sciences’ Phase 3 Study on KSI-101: A Potential Game-Changer for Macular Edema
3M ago
KOD
Kodiak Sciences upgraded to Overweight from Neutral at JPMorgan
PremiumThe FlyKodiak Sciences upgraded to Overweight from Neutral at JPMorgan
4M ago
KOD
JPMorgan healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
4M ago
KOD
Kodiak Sciences initiated with an Outperform at LifeSci Capital
Premium
The Fly
Kodiak Sciences initiated with an Outperform at LifeSci Capital
4M ago
KOD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >